Faeth: PIKTOR pivotal trial design expected 1H 2027 after Phase 2 endometrial dataNov 13Clinical readoutAbvc Biopharma, Inc.Actuate Therapeutics Inc.Updated
BioNTech to acquire FDA priority review voucher from Scholar Rock for $205 millionNov 10Regulatory milestoneBioNTech SE
Evaxion presents new EVX-01 immune data at SITC, showing ex vivo T-cell detectionNov 6Clinical readoutBioNTech SEEvaxion Biotech A/SUpdated
Pfizer raises 2026 guidance after Q3, reports pipeline progress and new CFONov 3Quarterly updateBioNTech SEC4 Therapeutics, Inc.
BioNTech, BMS report Phase 2 pumitamig data in NSCLC after immunotherapy progressionOct 26Clinical readoutBioNTech SEBristol Myers SquibbUpdated
BioNTech registers two first-in-human trials: BNT3219 and BNT3210 in advanced solid tumorsOct 23Weekly roundup, 2 itemsBioNTech SEUpdated
BMS posts RELATIVITY-106 liver cancer results; files two new Phase 1/2 trialsOct 16Weekly roundup, 4 itemsBioNTech SEBristol Myers SquibbUpdated
Boehringer Ingelheim registers Phase Ib/II trial testing obrixtamig plus pumitamig in SCLCOct 13Trial updateBioNTech SEBoehringer Ingelheim
Pfizer's Ruxience biosimilar supplement approved; breast cancer trials post resultsSep 30Weekly roundup, 8 itemsatirmociclibberobenatideUpdated
Boehringer Ingelheim registers Phase Ib/II trial pairing obrixtamig, pumitamig in SCLCSep 28Trial updateBioNTech SEBoehringer Ingelheim
BioNTech posts results for mpox vaccine BNT166a Phase I/II trial NCT05988203Sep 15Trial updateBioNTech SEBNT166A
CIBINQO label updated by FDA; Pfizer's rimegepant China trial and pipeline items still activeSep 3Weekly roundup, 7 itemsabrocitinibberobenatide
BioNTech ends Phase 2 trial of autogene cevumeran in colorectal cancerAug 28Clinical readoutautogene cevumeranBioNTech SE
BioNTech posts results for Phase I/IIa malaria RNA vaccine trial; CHMI portion skippedAug 28Trial updateBioNTech SEBNT165C
FDA approves updated Pfizer-BioNTech COVID-19 vaccine targeting XFG variantAug 27Regulatory decisionBioNTech SEPfizer
FDA approves ZAVZPRET label update; Pfizer registers RSVpreF and prostate cancer studiesAug 21Weekly roundup, 7 itemsBioNTech SEPenbraya
Genmab terminates Phase 1/2 GEN1055 trial for strategic reasons; results now postedAug 11Trial updateBioNTech SEGEN1055
BioNTech names Guido Oelkers CEO, trims 2026 revenue guidance in Q2 updateAug 4Quarterly updateBioNTech SE
Pfizer registers Phase 3 trials in alopecia areata and chronic migraine; two Phase 1 studies openJul 29Weekly roundup, 5 itemsBioNTech SEPF-08642534